The molecular basis of Human FN3K mediated phosphorylation of glycated substrate.
Ankur GargKin Fan OnYang XiaoElad ElkayamPaolo CifaniYael DavidLeemor Joshua-TorPublished in: bioRxiv : the preprint server for biology (2024)
Glycation, a non-enzymatic post-translational modification occurring on proteins, can be actively reversed via site-specific phosphorylation of the fructose-lysine moiety by FN3K kinase, to impact the cellular function of target protein. A regulatory axis between FN3K and glycated protein targets has been associated with conditions like diabetes and cancer. However the molecular basis of this relationship has not been explored so far. Here, we determined a series of crystal structures of HsFN3K in apo-state, and in complex with different nucleotide analogs together with a sugar substrate mimic to reveal the features important for its kinase activity and substrate recognition. Additionally, the dynamics in sugar substrate binding during the kinase catalytic cycle provide important mechanistic insights into HsFN3K function. Our structural work provides the molecular basis for rationale small molecule design targeting FN3K.
Keyphrases
- protein kinase
- amino acid
- small molecule
- protein protein
- tyrosine kinase
- endothelial cells
- type diabetes
- cardiovascular disease
- binding protein
- clinical trial
- transcription factor
- gene expression
- single cell
- cancer therapy
- hydrogen peroxide
- drug delivery
- dna methylation
- glycemic control
- nitric oxide
- pluripotent stem cells
- molecular dynamics simulations